Brief: Arcadia Biosciences Enters Inducement Offer Letter Agreements With Certain Investors - SEC Filing
14/01/2026 11:41
Jan 14 (Reuters) - SEC Filing: ARCADIA BIOSCIENCES INC - ENTERS INDUCEMENT OFFER LETTER AGREEMENTS WITH CERTAIN INVESTORS - SEC FILING ARCADIA BIOSCIENCES INC - INVESTORS TO PURCHASE 808,595 SHARES OF OF THE CO'S COMMON STOCK- SEC FILING Source text: [ID:n0001193125-26-012028] Further company coverage: RKDA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arcadia Biosciences
See all newsArcadia Biosciences Q1 revenue falls 8%, swings to loss
Brief: Arcadia Biosciences Q1 Net Income USD -4.385 Million
Arcadia Biosciences' Q4 revenue falls 26%, net loss narrows
Brief: Arcadia Biosciences Q4 Net Income USD -1.336 Million
Brief: Arcadia Biosciences Enters Inducement Offer Letter Agreements With Certain Investors - SEC Filing